Nelson Vergel
Founder, ExcelMale.com
Serum Testosterone (T) Level Variability in T Gel- Treated Older Hypogonadal Men: Treatment Monitoring Implications
Ronald S. Swerdloff et al
doi: 10.1210/JC.2015-1542 J Clin Endocrinol Metab
Context: The optimal frequency for on-treatment serum testosterone (T) measurement used for dose adjustment after transdermal T gel application is unknown, especially in older men with thinner skin and slower metabolic clearance.
Objectives: To determine variability of post-gel application serum T concentrations and assess whether single levels are reflective of average serum T concentrations over 24h (Cavg0 –24).
Design: A double-blinded, placebo-controlled randomized trial.
Setting: 5 academic centers.
Participants: 47 symptomatic men 65 y.o. with average of two morning T concentration <275 ng/dl.
Intervention(s): Transdermal T or placebo gel was applied for 120 + or - 14 days. Monthly dose adjustments were made if necessary to target serum T between 400/500 to 800 ng/dl.
Main Outcome Measures: Variability of serum T 2h post-gel application on 2 outpatient visits and at multiple time-points over 24h during the inpatient day.
Results: On-treatment T levels varied substantially on the two ambulatory days and over 24h during the inpatient day. Ambulatory 2h post-application T levels did not correlate significantly with either 2h post-application serum T or Cavg0 –24 measured during the inpatient day. Only 22.2% of men receiving T had Cavg0 –24 within the target range of 500 – 800ng/dl; 81.5% had Cavg0 –24 within the broader 300 –1000ng/dl range.
Conclusion: Large within-individual variations in serum T after T gel application render ambulatory 2h post-application T level a poor indicator of average serum T on another day. Our data point out the limitations of dose adjustments based on a single post-application serum T measurement.